Type 2 diabetes mellitus: New genetic insights will lead to new therapeutics

Current Genomics

Volumn 10, Issue 2, 2009, Pages 110-118

  Wolfs, M G M ^a   Hofker, M H ^a   Wijmenga, C ^b   van Haeften, T W ^a,c  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Drug targets; Genetics; Personalized medicine; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; INSULIN; METFORMIN; NEUROGENIC DIFFERENTIATION FACTOR; NOTCH2 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL KCNQ1; PRAMLINTIDE; SOMATOMEDIN BINDING PROTEIN 2; SULFONYLUREA DERIVATIVE; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR 7 LIKE 2; TRANSCRIPTION FACTOR PDX 1;

CALORIC INTAKE; DRUG TARGETING; ENVIRONMENTAL FACTOR; EXERCISE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HEREDITY; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MOLECULAR MECHANICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN SYNTHESIS INHIBITION; REVIEW;

EID: 65949099101     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920209787847023     Document Type: Review

References (49)

1. Newman, B., Selby, J.V., King, M.C., Slemenda, C., Fabsitz, R., Friedman, G.D. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987, 30: 763-768.
2. van Haeften, T.W., Dubbeldam, S., Zonderland, M.L., Erkelens, D.W. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests. Diabetes Care 1998, 21: 278-282.
3. Pimenta, W., Korytkowski, M., Mitrakou, A., Jenssen, T., Yki-Jarvinen, H., Evron, W., Dailey, G., Gerich, J. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a firstdegree NIDDM relative. Jama 1995, 273: 1855-1861.
4. Vaxillaire, M., Froguel, P. Monogenic diabetes in the young, pharmacogenetics and relevance to multifactorial forms of type 2 diabetes. Endocr. Rev. 2008, 29: 254-264.
5. Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B.N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., Kuroki, H., Kasahara, T., Iwamoto, Y., Bell, G.I. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat. Genet. 1997, 17: 384-385.
6. Strom, T.M., Hortnagel, K., Hofmann, S., Gekeler, F., Scharfe, C., Rabl, W., Gerbitz, K.D., Meitinger, T. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum. Mol. Genet. 1998, 7: 2021-2028.
7. Gloyn, A.L., Pearson, E.R., Antcliff, J.F., Proks, P., Bruining, G.J., Slingerland, A.S., Howard, N., Srinivasan, S., Silva, J.M., Molnes, J., Edghill, E.L., Frayling, T.M., Temple, I.K., Mackay, D., Shield, J.P., Sumnik, Z., van Rhijn, A., Wales, J.K., Clark, P., Gorman, S., Aisenberg, J., Ellard, S., Njolstad, P.R., Ashcroft, F.M., Hattersley, A.T. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med. 2004, 350: 1838-1849.
8. Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., Williams, T.D., Lewis, H., Schafer, A.J., Chatterjee, V.K., O'Rahilly, S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999, 402: 880-883.
9. Schadt, E.E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P.Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., Zhu, J., Millstein, J., Sieberts, S., Lamb, J., GuhaThakurta, D., Derry, J., Storey, J.D., Avila-Campillo, I., Kruger, M.J., Johnson, J.M., Rohl, C.A., van Nas, A., Mehrabian, M., Drake, T.A., Lusis, A.J., Smith, R.C., Guengerich, F.P., Strom, S.C., Schuetz, E., Rushmore, T.H., Ulrich, R. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 2008, 6: e107.
10. McCarthy, M.I., Abecasis, G.R., Cardon, L.R., Goldstein, D.B., Little, J., Ioannidis, J.P., Hirschhorn, J.N. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet. 2008, 9: 356-369.
11. Florez, J.C., Manning, A.K., Dupuis, J., McAteer, J., Irenze, K., Gianniny, L., Mirel, D.B., Fox, C.S., Cupples, L.A., Meigs, J.B. A 100K genome-wide association scan for diabetes and related traits in the Framingham Heart Study: replication and integration with other genome-wide datasets. Diabetes 2007, 56: 3063-3074.
12. Frayling, T.M. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat. Rev. Genet. 2007, 8: 657-662.
13. Hanson, R.L., Bogardus, C., Duggan, D., Kobes, S., Knowlton, M., Infante, A.M., Marovich, L., Benitez, D., Baier, L.J., Knowler, W.C. A search for variants associated with young-onset type 2 diabetes in American Indians in a 100K genotyping array. Diabetes 2007, 56: 3045-3052.
14. Hayes, M.G., Pluzhnikov, A., Miyake, K., Sun, Y., Ng, M.C., Roe, C.A., Below, J.E., Nicolae, R.I., Konkashbaev, A., Bell, G.I., Cox, N.J., Hanis, C.L. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 2007, 56: 3033-3044.
15. Rampersaud, E., Damcott, C.M., Fu, M., Shen, H., McArdle, P., Shi, X., Shelton, J., Yin, J., Chang, Y.P., Ott, S.H., Zhang, L., Zhao, Y., Mitchell, B.D., O'Connell, J., Shuldiner, A.R. Identification of novel candidate genes for type 2 diabetes from a genomewide association scan in the Old Order Amish: evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 2007, 56: 3053-3062.
16. Salonen, J.T., Uimari, P., Aalto, J.M., Pirskanen, M., Kaikkonen, J., Todorova, B., Hypponen, J., Korhonen, V.P., Asikainen, J., Devine, C., Tuomainen, T.P., Luedemann, J., Nauck, M., Kerner, W., Stephens, R.H., New, J.P., Ollier, W.E., Gibson, J.M., Payton, A., Horan, M.A., Pendleton, N., Mahoney, W., Meyre, D., Delplanque, J., Froguel, P., Luzzatto, O., Yakir, B., Darvasi, A. Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium. Am. J. Hum. Genet. 2007, 81: 338-345.
17. Saxena, R., Voight, B.F., Lyssenko, V., Burtt, N.P., de Bakker, P.I., Chen, H., Roix, J.J., Kathiresan, S., Hirschhorn, J.N., Daly, M.J., Hughes, T.E., Groop, L., Altshuler, D., Almgren, P., Florez, J.C., Meyer, J., Ardlie, K., Bengtsson Bostrom, K., Isomaa, B., Lettre, G., Lindblad, U., Lyon, H.N., Melander, O., Newton-Cheh, C., Nilsson, P., Orho-Melander, M., Rastam, L., Speliotes, E.K., Taskinen, M.R., Tuomi, T., Guiducci, C., Berglund, A., Carlson, J., Gianniny, L., Hackett, R., Hall, L., Holmkvist, J., Laurila, E., Sjogren, M., Sterner, M., Surti, A., Svensson, M., Svensson, M., Tewhey, R., Blumenstiel, B., Parkin, M., Defelice, M., Barry, R., Brodeur, W., Camarata, J., Chia, N., Fava, M., Gibbons, J., Handsaker, B., Healy, C., Nguyen, K., Gates, C., Sougnez, C., Gage, D., Nizzari, M., Gabriel, S.B., Chirn, G.W., Ma, Q., Parikh, H., Richardson, D., Ricke, D., Purcell, S. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007, 316: 1331-1336.
18. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., Willer, C.J., Li, Y., Duren, W.L., Erdos, M.R., Stringham, H.M., Chines, P.S., Jackson, A.U., Prokunina-Olsson, L., Ding, C.J., Swift, A.J., Narisu, N., Hu, T., Pruim, R., Xiao, R., Li, X.Y., Conneely, K.N., Riebow, N.L., Sprau, A.G., Tong, M., White, P.P., Hetrick, K.N., Barnhart, M.W., Bark, C.W., Goldstein, J.L., Watkins, L., Xiang, F., Saramies, J., Buchanan, T.A., Watanabe, R.M., Valle, T.T., Kinnunen, L., Abecasis, G.R., Pugh, E.W., Doheny, K.F., Bergman, R.N., Tuomilehto, J., Collins, F.S., Boehnke, M. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 2007, 316: 1341-1345.
19. Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., Balkau, B., Heude, B., Charpentier, G., Hudson, T.J., Montpetit, A., Pshezhetsky, A.V., Prentki, M., Posner, B.I., Balding, D.J., Meyre, D., Polychronakos, C., Froguel, P. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 2007, 445: 881-885.
20. Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G.B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V., Ghosh, S., Baker, A., Snorradottir, S., Bjarnason, H., Ng, M.C., Hansen, T., Bagger, Y., Wilensky, R.L., Reilly, M.P., Adeyemo, A., Chen, Y., Zhou, J., Gudnason, V., Chen, G., Huang, H., Lashley, K., Doumatey, A., So, W.Y., Ma, R.C., Andersen, G., Borch-Johnsen, K., Jorgensen, T., van Vliet-Ostaptchouk, J.V., Hofker, M.H., Wijmenga, C., Christiansen, C., Rader, D.J., Rotimi, C., Gurney, M., Chan, J.C., Pedersen, O., Sigurdsson, G., Gulcher, J.R., Thorsteinsdottir, U., Kong, A., Stefansson, K. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 2007, 39: 770-775.
21. Unoki, H., Takahashi, A., Kawaguchi, T., Hara, K., Horikoshi, M., Andersen, G., Ng, D.P., Holmkvist, J., Borch-Johnsen, K., Jorgensen, T., Sandbaek, A., Lauritzen, T., Hansen, T., Nurbaya, S., Tsunoda, T., Kubo, M., Babazono, T., Hirose, H., Hayashi, M., Iwamoto, Y., Kashiwagi, A., Kaku, K., Kawamori, R., Tai, E.S., Pedersen, O., Kamatani, N., Kadowaki, T., Kikkawa, R., Nakamura, Y., Maeda, S. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat. Genet. 2008, 40: 1098-1102.
22. Yasuda, K., Miyake, K., Horikawa, Y., Hara, K., Osawa, H., Furuta, H., Hirota, Y., Mori, H., Jonsson, A., Sato, Y., Yamagata, K., Hinokio, Y., Wang, H.Y., Tanahashi, T., Nakamura, N., Oka, Y., Iwasaki, N., Iwamoto, Y., Yamada, Y., Seino, Y., Maegawa, H., Kashiwagi, A., Takeda, J., Maeda, E., Shin, H.D., Cho, Y.M., Park, K.S., Lee, H.K., Ng, M.C., Ma, R.C., So, W.Y., Chan, J.C., Lyssenko, V., Tuomi, T., Nilsson, P., Groop, L., Kamatani, N., Sekine, A., Nakamura, Y., Yamamoto, K., Yoshida, T., Tokunaga, K., Itakura, M., Makino, H., Nanjo, K., Kadowaki, T., Kasuga, M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 2008, 40: 1092-1097.
23. Zeggini, E., Scott, L.J., Saxena, R., Voight, B.F., Marchini, J.L., Hu, T., de Bakker, P.I., Abecasis, G.R., Almgren, P., Andersen, G., Ardlie, K., Bostrom, K.B., Bergman, R.N., Bonnycastle, L.L., Borch-Johnsen, K., Burtt, N.P., Chen, H., Chines, P.S., Daly, M.J., Deodhar, P., Ding, C.J., Doney, A.S., Duren, W.L., Elliott, K.S., Erdos, M.R., Frayling, T.M., Freathy, R.M., Gianniny, L., Grallert, H., Grarup, N., Groves, C.J., Guiducci, C., Hansen, T., Herder, C., Hitman, G.A., Hughes, T.E., Isomaa, B., Jackson, A.U., Jorgensen, T., Kong, A., Kubalanza, K., Kuruvilla, F.G., Kuusisto, J., Langenberg, C., Lango, H., Lauritzen, T., Li, Y., Lindgren, C.M., Lyssenko, V., Marvelle, A.F., Meisinger, C., Midthjell, K., Mohlke, K.L., Morken, M.A., Morris, A.D., Narisu, N., Nilsson, P., Owen, K.R., Palmer, C.N., Payne, F., Perry, J.R., Pettersen, E., Platou, C., Prokopenko, I., Qi, L., Qin, L., Rayner, N.W., Rees, M., Roix, J.J., Sandbaek, A., Shields, B., Sjogren, M., Steinthorsdottir, V., Stringham, H.M., Swift, A.J., Thorleifsson, G., Thorsteinsdottir, U., Timpson, N.J., Tuomi, T., Tuomilehto, J., Walker, M., Watanabe, R.M., Weedon, M.N., Willer, C.J., Illig, T., Hveem, K., Hu, F.B., Laakso, M., Stefansson, K., Pedersen, O., Wareham, N.J., Barroso, I., Hattersley, A.T., Collins, F.S., Groop, L., McCarthy, M.I., Boehnke, M., Altshuler, D. Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat. Genet. 2008, 40: 638-645.
24. Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H., Timpson, N.J., Perry, J.R., Rayner, N.W., Freathy, R.M., Barrett, J.C., Shields, B., Morris, A.P., Ellard, S., Groves, C.J., Harries, L.W., Marchini, J.L., Owen, K.R., Knight, B., Cardon, L.R., Walker, M., Hitman, G.A., Morris, A.D., Doney, A.S., McCarthy, M.I., Hattersley, A.T. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 2007, 316: 1336-1341.
25. Lango, H., Palmer, C.N., Morris, A.D., Zeggini, E., Hattersley, A.T., McCarthy, M.I., Frayling, T.M., Weedon, M.N. Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 2008, 57: 3129-3135.
26. van Hoek, M., Dehgan, A., Witteman, J.C., van Duijn, C.M., Uitterlinden, A.G., Oostra, B.A., Hofman, A., Sijbrands, E.J., Janssens, A.C. Predicting type 2 diabetes based on polymorphisms from genome wide association studies: a population-based study. Diabetes 2008, 57: 3122-3128.
27. Stumvoll, M., Goldstein, B.J., van Haeften, T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365: 1333-1346.
28. Inagaki, N., Gonoi, T., Clement, J.P.t., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Seino, S., Bryan, J. Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995, 270: 1166-1170.
29. Wang, L., Coffinier, C., Thomas, M.K., Gresh, L., Eddu, G., Manor, T., Levitsky, L.L., Yaniv, M., Rhoads, D.B. Selective deletion of the Hnf1beta (MODY5) gene in beta-cells leads to altered gene expression and defective insulin release. Endocrinology 2004, 145: 3941-3949.
30. Yamada, T., Ishihara, H., Tamura, A., Takahashi, R., Yamaguchi, S., Takei, D., Tokita, A., Satake, C., Tashiro, F., Katagiri, H., Aburatani, H., Miyazaki, J., Oka, Y. WFS1-deficiency increases endoplasmic reticulum stress, impairs cell cycle progression and triggers the apoptotic pathway specifically in pancreatic beta-cells. Hum. Mol. Genet. 2006, 15: 1600-1609.
31. Stumvoll, M., Haring, H. The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism. Diabetes 2002, 51: 2341-2347.
32. Grarup, N., Andersen, G., Krarup, N.T., Albrechtsen, A., Schmitz, O., Jorgensen, T., Borch-Johnsen, K., Hansen, T., Pedersen, O. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/ CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middleaged Danes. Diabetes 2008, 57: 2534-2540.
33. Grarup, N., Rose, C.S., Andersson, E.A., Andersen, G., Nielsen, A.L., Albrechtsen, A., Clausen, J.O., Rasmussen, S.S., Jorgensen, T., Sandbaek, A., Lauritzen, T., Schmitz, O., Hansen, T., Pedersen, O. Studies of association of variants near the HHEX, CDKN2A/B, and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 2007, 56: 3105-3111.
34. Pascoe, L., Tura, A., Patel, S.K., Ibrahim, I.M., Ferrannini, E., Zeggini, E., Weedon, M.N., Mari, A., Hattersley, A.T., McCarthy, M.I., Frayling, T.M., Walker, M. Common variants of the novel type 2 diabetes genes CDKAL1 and HHEX/IDE are associated with decreased pancreatic beta-cell function. Diabetes 2007, 56: 3101-3104.
35. Staiger, H., Machicao, F., Kantartzis, K., Schafer, S.A., Kirchhoff, K., Guthoff, M., Silbernagel, G., Stefan, N., Fritsche, A., Haring, H.U. Novel meta-analysis-derived type 2 diabetes risk loci do not determine prediabetic phenotypes. PLoS ONE 2008, 3: e3019.
36. Staiger, H., Machicao, F., Stefan, N., Tschritter, O., Thamer, C., Kantartzis, K., Schafer, S.A., Kirchhoff, K., Fritsche, A., Haring, H.U. Polymorphisms within novel risk loci for type 2 diabetes determine beta-cell function. PLoS ONE 2007, 2: e832.
37. Doria, A., Patti, M.E., Kahn, C.R. The emerging genetic architecture of type 2 diabetes. Cell Metab. 2008, 8: 186-200.
38. Jin, T. The WNT signalling pathway and diabetes mellitus. Diabetologia 2008, 51: 1771-1780.
39. Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J.T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B.A., Baker, A., Sigurdsson, A., Benediktsdottir, K.R., Jakobsdottir, M., Blondal, T., Stacey, S.N., Helgason, A., Gunnarsdottir, S., Olafsdottir, A., Kristinsson, K.T., Birgisdottir, B., Ghosh, S., Thorlacius, S., Magnusdottir, D., Stefansdottir, G., Kristjansson, K., Bagger, Y., Wilensky, R.L., Reilly, M.P., Morris, A.D., Kimber, C.H., Adeyemo, A., Chen, Y., Zhou, J., So, W.Y., Tong, P.C., Ng, M.C., Hansen, T., Andersen, G., Borch-Johnsen, K., Jorgensen, T., Tres, A., Fuertes, F., Ruiz-Echarri, M., Asin, L., Saez, B., van Boven, E., Klaver, S., Swinkels, D.W., Aben, K.K., Graif, T., Cashy, J., Suarez, B.K., van Vierssen Trip, O., Frigge, M.L., Ober, C., Hofker, M.H., Wijmenga, C., Christiansen, C., Rader, D.J., Palmer, C.N., Rotimi, C., Chan, J.C., Pedersen, O., Sigurdsson, G., Benediktsson, R., Jonsson, E., Einarsson, G.V., Mayordomo, J.I., Catalona, W.J., Kiemeney, L.A., Barkardottir, R.B., Gulcher, J.R., Thorsteinsdottir, U., Kong, A., Stefansson, K. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat. Genet. 2007, 39: 977-983.
40. Thomas, G., Jacobs, K.B., Yeager, M., Kraft, P., Wacholder, S., Orr, N., Yu, K., Chatterjee, N., Welch, R., Hutchinson, A., Crenshaw, A., Cancel-Tassin, G., Staats, B.J., Wang, Z., Gonzalez-Bosquet, J., Fang, J., Deng, X., Berndt, S.I., Calle, E.E., Feigelson, H.S., Thun, M.J., Rodriguez, C., Albanes, D., Virtamo, J., Weinstein, S., Schumacher, F.R., Giovannucci, E., Willett, W.C., Cussenot, O., Valeri, A., Andriole, G.L., Crawford, E.D., Tucker, M., Gerhard, D.S., Fraumeni, J.F., Jr., Hoover, R., Hayes, R.B., Hunter, D.J., Chanock, S.J. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 2008, 40: 310-315.
41. Eeles, R.A., Kote-Jarai, Z., Giles, G.G., Olama, A.A., Guy, M., Jugurnauth, S.K., Mulholland, S., Leongamornlert, D.A., Edwards, S.M., Morrison, J., Field, H.I., Southey, M.C., Severi, G., Donovan, J.L., Hamdy, F.C., Dearnaley, D.P., Muir, K.R., Smith, C., Bagnato, M., Ardern-Jones, A.T., Hall, A.L., O'Brien, L.T., Gehr-Swain, B.N., Wilkinson, R.A., Cox, A., Lewis, S., Brown, P.M., Jhavar, S.G., Tymrakiewicz, M., Lophatananon, A., Bryant, S.L., Horwich, A., Huddart, R.A., Khoo, V.S., Parker, C.C., Woodhouse, C.J., Thompson, A., Christmas, T., Ogden, C., Fisher, C., Jamieson, C., Cooper, C.S., English, D.R., Hopper, J.L., Neal, D.E., Easton, D.F. Multiple newly identified loci associated with prostate cancer susceptibility. Nat. Genet. 2008, 40: 316-321.
42. Tuomilehto, J., Lindstrom, J., Eriksson, J.G., Valle, T.T., Hamalainen, H., Ilanne-Parikka, P., Keinanen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001, 344: 1343-1350.
43. Knowler, W.C., Barrett-Connor, E., Fowler, S.E., Hamman, R.F., Lachin, J.M., Walker, E.A., Nathan, D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002, 346: 393-403.
44. Hattersley, A.T., Pearson, E.R. Minireview: pharmacogenetics and beyond: the interaction of therapeutic response, beta-cell physiology, and genetics in diabetes. Endocrinology 2006, 147: 2657-2663.
45. Drucker, D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol. Endocrinol. 2003, 17: 161-171.
46. Elbrecht, A., Chen, Y., Cullinan, C.A., Hayes, N., Leibowitz, M., Moller, D.E., Berger, J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 1996, 224: 431-437.
47. Leitzmann, M.F., Ahn, J., Albanes, D., Hsing, A.W., Schatzkin, A., Chang, S.C., Huang, W.Y., Weiss, J.M., Danforth, K.N., Grubb, R.L., 3rd, Andriole, G.L. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control 2008, 19: 1267-1276.
48. Kirchhoff, K., Machicao, F., Haupt, A., Schafer, S.A., Tschritter, O., Staiger, H., Stefan, N., Haring, H.U., Fritsche, A. Polymorphisms in the TCF7L2, CDKAL1 and SLC30A8 genes are associated with impaired proinsulin conversion. Diabetologia 2008, 51: 597-601.
49. Jain, K., Logothetopoulos, J. Secretion of insulin in a perifusion system and conversion of proinsulin to insulin by pancreatic islets from hyperglycemic rats. Diabetes 1977, 26: 650-656.